BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9022439)

  • 21. Hepatitis after sevoflurane exposure in an infant suffering from primary hyperoxaluria type 1.
    Reich A; Everding AS; Bulla M; Brinkmann OA; Van Aken H
    Anesth Analg; 2004 Aug; 99(2):370-2, table of contents. PubMed ID: 15271707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sevoflurane in paediatric anaesthesia: a review.
    Goa KL; Noble S; Spencer CM
    Paediatr Drugs; 1999; 1(2):127-53. PubMed ID: 10937447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the induction and emergence characteristics of sevoflurane and halothane in children.
    Chiu CL; Chan YK; Ong G; Delilkan AE
    Med J Malaysia; 1999 Sep; 54(3):346-51. PubMed ID: 11045061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative study of recovery from general anesthesia with halothane or sevoflurane in pediatrics].
    Calderón E; Torres LM
    Rev Esp Anestesiol Reanim; 1996 Oct; 43(8):272-5. PubMed ID: 9011896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Seizure-like movements following sevoflurane induction in paediatric anaesthesia].
    Zeidan A; Maaliki H; Hajjar W
    Ann Fr Anesth Reanim; 2004 Mar; 23(2):160-1. PubMed ID: 15030868
    [No Abstract]   [Full Text] [Related]  

  • 26. Spontaneous hyperactivity in mutant mice lacking the NMDA receptor GluRepsilon1 subunit is aggravated during exposure to 0.1 MAC sevoflurane and is preserved after emergence from sevoflurane anaesthesia.
    Petrenko AB; Kohno T; Wu J; Sakimura K; Baba H
    Eur J Anaesthesiol; 2008 Dec; 25(12):953-60. PubMed ID: 18990258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of volatile anesthetics on the Q-Tc interval.
    Güler N; Kati I; Demirel CB; Bilge M; Eryonucu B; Topal C
    J Cardiothorac Vasc Anesth; 2001 Apr; 15(2):188-91. PubMed ID: 11312477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Halothane, dental anaesthesia and children.
    Terry D
    SAAD Dig; 2000 Jan; 17(1):26. PubMed ID: 11404913
    [No Abstract]   [Full Text] [Related]  

  • 29. [Sevoflurane (SEVOrane) as an inhalation anesthetic in dogs in comparison with halothane and isoflurane].
    Tacke S; Xiong H; Schimke E
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 1998 Nov; 26(6):369-77. PubMed ID: 9857416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of sevoflurane with halothane in pediatric ambulatory anesthesia: an experience in Taiwan.
    Chong ZK; Jawan B; Poon YY; Lee JH
    Acta Anaesthesiol Sin; 1997 Mar; 35(1):21-4. PubMed ID: 9212477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Observational audit of sevoflurane consumption during paediatric anaesthesia.
    van der Griend BF; Vincent AR; Kennedy RR
    Anaesth Intensive Care; 2019 May; 47(3):251-254. PubMed ID: 31165625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sevoflurane.
    Moulton C; Dark P
    J Accid Emerg Med; 1998 May; 15(3):207-8. PubMed ID: 9639196
    [No Abstract]   [Full Text] [Related]  

  • 33. Halothane: the last word?
    Holzki J
    Paediatr Anaesth; 2001 Mar; 11(2):249-52. PubMed ID: 11240888
    [No Abstract]   [Full Text] [Related]  

  • 34. Severe hepatic dysfunction after sevoflurane exposure.
    Alotaibi WM
    Saudi Med J; 2008 Sep; 29(9):1344-6. PubMed ID: 18813426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Letter: "Hepatitis after use of two different fluorinated anesthetic agents".
    Anesth Analg; 1975; 54(1):125-32. PubMed ID: 1167748
    [No Abstract]   [Full Text] [Related]  

  • 36. Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.
    Patel SS; Goa KL
    Drugs; 1996 Apr; 51(4):658-700. PubMed ID: 8706599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The performance of Bispectral Index in children during equi-MAC halothane vs. sevoflurane anaesthesia.
    Taivainen T; Klockars J; Hiller A; Wennervirta J; van Gils MJ; Suominen P
    Eur J Anaesthesiol; 2008 Nov; 25(11):933-9. PubMed ID: 18652710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Halothane and post-halothane exposure hepatitis.
    Buchanan CC; Cameron RJ; Carpenter RD; Currie J; Spencer HT
    N Z Med J; 1999 Jan; 112(1080):19-20. PubMed ID: 10073163
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparison of sevoflurane with halothane for paediatric day case surgery.
    Walker SM; Haugen RD; Richards A
    Anaesth Intensive Care; 1997 Dec; 25(6):643-9. PubMed ID: 9452847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatal hepatotoxicity due to sevoflurane use in a paediatric patient after aortic repair: reality or fiction? A case of pharmacovigilance.
    Sanchez LV; Pichardo P; Adames V; Zovi A; Pradegan N
    Eur J Hosp Pharm; 2023 Jan; 30(1):57-59. PubMed ID: 33832917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.